These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35989899)

  • 21. Repeats expansions in
    Nel M; Mavundla T; Gultig K; Botha G; Mulder N; Benatar M; Wuu J; Cooley A; Myers J; Rampersaud E; Wu G; Heckmann JM
    IBRO Neurosci Rep; 2021 Jun; 10():130-135. PubMed ID: 34179866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry.
    Borghero G; Pugliatti M; Marrosu F; Marrosu MG; Murru MR; Floris G; Cannas A; Parish LD; Cau TB; Loi D; Ticca A; Traccis S; Manera U; Canosa A; Moglia C; Calvo A; Barberis M; Brunetti M; Renton AE; Nalls MA; Traynor BJ; Restagno G; Chiò A;
    Neurobiol Aging; 2015 Oct; 36(10):2906.e1-5. PubMed ID: 26208502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATXN2 trinucleotide repeat length correlates with risk of ALS.
    Sproviero W; Shatunov A; Stahl D; Shoai M; van Rheenen W; Jones AR; Al-Sarraj S; Andersen PM; Bonini NM; Conforti FL; Van Damme P; Daoud H; Del Mar Amador M; Fogh I; Forzan M; Gaastra B; Gellera C; Gitler AD; Hardy J; Fratta P; La Bella V; Le Ber I; Van Langenhove T; Lattante S; Lee YC; Malaspina A; Meininger V; Millecamps S; Orrell R; Rademakers R; Robberecht W; Rouleau G; Ross OA; Salachas F; Sidle K; Smith BN; Soong BW; Sorarù G; Stevanin G; Kabashi E; Troakes C; van Broeckhoven C; Veldink JH; van den Berg LH; Shaw CE; Powell JF; Al-Chalabi A
    Neurobiol Aging; 2017 Mar; 51():178.e1-178.e9. PubMed ID: 28017481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
    Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
    J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci.
    He F; Jones JM; Figueroa-Romero C; Zhang D; Feldman EL; Goutman SA; Meisler MH; Callaghan BC; Todd PK
    Neurol Genet; 2016 Jun; 2(3):e71. PubMed ID: 27274540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72.
    Snowden JS; Harris J; Richardson A; Rollinson S; Thompson JC; Neary D; Mann DM; Pickering-Brown S
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):172-6. PubMed ID: 23421625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.
    van Blitterswijk M; Mullen B; Heckman MG; Baker MC; DeJesus-Hernandez M; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Neumann M; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
    Neurobiol Aging; 2014 Oct; 35(10):2421.e13-7. PubMed ID: 24866401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate-length polyglutamine in ATXN2 is a possible risk factor among Eastern Chinese patients with amyotrophic lateral sclerosis.
    Lu HP; Gan SR; Chen S; Li HF; Liu ZJ; Ni W; Wang N; Wu ZY
    Neurobiol Aging; 2015 Mar; 36(3):1603.e11-4. PubMed ID: 25457026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-read sequencing across the C9orf72 'GGGGCC' repeat expansion: implications for clinical use and genetic discovery efforts in human disease.
    Ebbert MTW; Farrugia SL; Sens JP; Jansen-West K; Gendron TF; Prudencio M; McLaughlin IJ; Bowman B; Seetin M; DeJesus-Hernandez M; Jackson J; Brown PH; Dickson DW; van Blitterswijk M; Rademakers R; Petrucelli L; Fryer JD
    Mol Neurodegener; 2018 Aug; 13(1):46. PubMed ID: 30126445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.
    van Blitterswijk M; DeJesus-Hernandez M; Niemantsverdriet E; Murray ME; Heckman MG; Diehl NN; Brown PH; Baker MC; Finch NA; Bauer PO; Serrano G; Beach TG; Josephs KA; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Boylan KB; Petrucelli L; Dickson DW; Rademakers R
    Lancet Neurol; 2013 Oct; 12(10):978-88. PubMed ID: 24011653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the phenotype of Italian patients with ALS with intermediate
    Chio A; Moglia C; Canosa A; Manera U; Grassano M; Vasta R; Palumbo F; Gallone S; Brunetti M; Barberis M; De Marchi F; Dalgard C; Chia R; Mora G; Iazzolino B; Peotta L; Traynor B; Corrado L; D'Alfonso S; Mazzini L; Calvo A
    J Neurol Neurosurg Psychiatry; 2022 Aug; 93(11):1216-20. PubMed ID: 36008116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.
    Byrne S; Elamin M; Bede P; Shatunov A; Walsh C; Corr B; Heverin M; Jordan N; Kenna K; Lynch C; McLaughlin RL; Iyer PM; O'Brien C; Phukan J; Wynne B; Bokde AL; Bradley DG; Pender N; Al-Chalabi A; Hardiman O
    Lancet Neurol; 2012 Mar; 11(3):232-40. PubMed ID: 22305801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis.
    Figley MD; Thomas A; Gitler AD
    Neurobiol Aging; 2014 Apr; 35(4):936.e1-4. PubMed ID: 24269018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis.
    Lattante S; Pomponi MG; Conte A; Marangi G; Bisogni G; Patanella AK; Meleo E; Lunetta C; Riva N; Mosca L; Carrera P; Bee M; Zollino M; Sabatelli M
    Neurobiol Aging; 2018 Apr; 64():157.e1-157.e5. PubMed ID: 29274668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Association between C9orf72 Repeats and Risk of Alzheimer's Disease and Amyotrophic Lateral Sclerosis: A Meta-Analysis.
    Shu L; Sun Q; Zhang Y; Xu Q; Guo J; Yan X; Tang B
    Parkinsons Dis; 2016; 2016():5731734. PubMed ID: 27375918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Analysis of
    Trojsi F; Siciliano M; Femiano C; Santangelo G; Lunetta C; Calvo A; Moglia C; Marinou K; Ticozzi N; Ferro C; Scialò C; Sorarù G; Conte A; Falzone YM; Tortelli R; Russo M; Sansone VA; Chiò A; Mora G; Silani V; Volanti P; Caponnetto C; Querin G; Sabatelli M; Riva N; Logroscino G; Messina S; Fasano A; Monsurrò MR; Tedeschi G; Mandrioli J
    Front Neurosci; 2019; 13():485. PubMed ID: 31156370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and genetic features of amyotrophic lateral sclerosis patients with
    Wiesenfarth M; Günther K; Müller K; Witzel S; Weiland U; Mayer K; Herrmann C; Brenner D; Schuster J; Freischmidt A; Lulé D; Meyer T; Regensburger M; Grehl T; Emmer A; Petri S; Großkreutz J; Rödiger A; Steinbach R; Klopstock T; Reilich P; Schöberl F; Wolf J; Hagenacker T; Weyen U; Zeller D; Ludolph AC; Dorst J
    Brain Commun; 2023; 5(2):fcad087. PubMed ID: 37006326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations.
    Naruse H; Matsukawa T; Ishiura H; Mitsui J; Takahashi Y; Takano H; Goto J; Toda T; Tsuji S
    Neurogenetics; 2019 May; 20(2):65-71. PubMed ID: 30847648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?
    van Blitterswijk M; DeJesus-Hernandez M; Rademakers R
    Curr Opin Neurol; 2012 Dec; 25(6):689-700. PubMed ID: 23160421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.